Daytrana® is a medicinal patch containing methylphenidate which is used to treat Attention Deficit Hyperactivity Disorder (ADHD). The patch is available in most countries by prescription only and response and tolerance will be monitored closely by the treating doctor. Daytrana® may be known by different trade names in different countries, according to manufacturer.
ADHD is a behavioral disorder found most commonly in children, most often boys, but is not limited to childhood. It manifests with symptoms such as difficulty concentrating, restlessness, fidgeting and a short attention span. These symptoms are commonly seen characteristics of childhood so professional diagnosis of ADHD is necessary. Non-drug measures, such as psychological, social and educational therapies may be sufficient to treat mild cases but medication may need to be added to these in more severe cases.
The active ingredient in Daytrana®, methylphenidate, is a stimulant medication related to amphetamines. It works by stimulating dopamine and noradrenalin, which are chemicals in the brain involved in the control of attention and behavior. These chemicals are thought to be underactive in some children with ADHD.
Daytrana® is usually given on a daily basis with the patch being applied each day for a specific number of hours. It is usually placed on clean, dry, undamaged skin of the hip two hours before the effect is required and may be left on for up to nine hours. There are a number of different strengths of patches available and the dose may be titrated up by the prescribing doctor, according to tolerance and response. Drug-free periods may be recommended and the prescribed dose should never be exceeded. All medication should be kept safely locked away, out of reach of children.
As with any medication, Daytrana® may be contraindicated in people with some underlying clinical conditions, such as cardiac disorders. These should be discussed with the treating doctor before starting treatment with the drug. It may also interact with other medications, including homeopathic, over-the-counter and homeopathic preparations, so these should also be disclosed to the doctor.
The side effects which may be experienced while taking Daytrana® include insomnia, restlessness, headache and palpitations. When used long-term in children, reduced weight and height may be experienced, which will be closely monitored by the treating doctor. Methylphenidate has the potential for addiction so only the therapeutic dose should be used, only for the period of time necessary. Again, the prescribing doctor will monitor the treatment period, which may be prolonged.
